首页> 外文OA文献 >Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells

【2h】

Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells

机译：rad51在人肺癌细胞中表皮生长因子受体抑制剂（Gefitinib，Iressar）和化学治疗剂诱导的细胞毒性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J.-C. Ko; S.-C. Ciou; C.-M. Cheng; L.-H. Wang; J.-H. Hong; M.-Y. Jheng; S.-T. Ling; Y.-W. Lin;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells. [J] . Ko JC, Ciou SC, Cheng CM, Carcinogenesis . 2008,第7期

机译：Rad51参与人肺癌细胞中由表皮生长因子受体抑制剂（吉非替尼，IreessaR）和化学治疗剂诱导的细胞毒性。
2. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells [J] . Jen-Chung Ko Shih-Ci Ciou1 Chau-Ming Cheng1 Lyu-Han Wang1 Jhao-Hao Hong1 Ming-Yan Jheng1 Szu-Ting Ling1 and Yun-Wei Lin1* Carcinogenesis . 2008,第7期

机译：Rad51参与表皮生长因子受体抑制剂（吉非替尼，易瑞沙 R ）和化学治疗剂诱导的人肺癌细胞毒性
3. Gefitinib enhances cytotoxicities of antimicrotubule agents in non-small-cell lung cancer cells exhibiting no sensitizing epidermal growth factor receptor mutation [J] . TsaiC.-M., ChiuC.-H., ChangK.-T., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2012,第8期

机译：吉非替尼可增强抗微管药在非敏化表皮生长因子受体突变的非小细胞肺癌细胞中的细胞毒性
4. Steroid Receptor and Growth Factor Receptor Expression in Human Nonsmall Cell Lung Cancers Using Cells Procured by Laser-capture Microdissection [C] . Alan Kerr, II, James F. Eliason, International Symposium on Hormonal Carcinogenesis . 2008

机译：使用激光捕获微散射采购的细胞，使用激光捕获微粉的细胞的类固醇受体和生长因子受体表达
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib (Iressa™) and to the antiangiogenic agent ZD6474: Cytotoxic and biomolecular effects [O] . Amalia Azzariti, Letizia Porcelli, Jian-Ming Xu, 2006

机译：结肠癌细胞长时间暴露于表皮生长因子受体抑制剂吉非替尼（Iressa™）和抗血管生成剂ZD6474：细胞毒性和生物分子作用
7. Gefitinib Enhances Cytotoxicities of Antimicrotubule Agents in Non–Small-Cell Lung Cancer Cells Exhibiting No Sensitizing Epidermal Growth Factor Receptor Mutation [O] . Tsai Chun-Ming, Chiu Chao-Hua, Chang Kao-Ting, 2012

机译：吉非替尼可增强抗微管剂在非敏化表皮生长因子受体突变的非小细胞肺癌细胞中的细胞毒性
8. Modulation of Epidermal Growth Factor Receptor Expression by Chemotherapeutic Agents in Breast Cancer Cell Lines [R] . Welch, J. N. 2002

机译：化学治疗剂对乳腺癌细胞系中表皮生长因子受体表达的调节作用

Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells

著录项

引文网络

相似文献

相关主题

期刊订阅